WSK-IM02 not checked

WestVac Biopharma Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
2 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“3.33 μg/kg, 8.33 μg/kg, or 16.67 μg/kg of WSK-IM02 as monotherapy via intraperitoneal injection.”In the company’s words, NCT07462468 on ClinicalTrials.gov
Tested for
Platinum-resistant Recurrent Ovarian Cancer (PROC), Advanced Solid Tumors, Malignant Pleural Effusions, Malignant Ascites
Main trialPhase 1
“A Phase 1, single-arm, single-center, open-label, prospective, dose-escalation, and cohort expansion study to assess the safety, tolerability, pharmacokinetic (PK), and preliminary efficacy of WSK-IM02 administered as a single agent to patients with platinum-resistant recurrent ovarian cancer.”In the company’s words, NCT07462468 on ClinicalTrials.gov

Other drugs for Platinum-resistant Recurrent Ovarian Cancer (PROC)

All 265 drugs for Platinum-resistant Recurrent Ovarian Cancer (PROC)

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 1Not yet recruiting 31 Mar 2027 A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Phase 1Not yet recruiting 30 Jan 2028 WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow WSK-IM02

Following is part of Solo: you see every change to WSK-IM02 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in